Shares of Lupin Ltd crashed 5% on 11 February despite the US Food and Drug Administration’s (USFDA) approval of the company’s nasal spray. The USFDA...
Shares of Lupin Ltd were trading in the green and 1% higher on 9 January despite the company’s Pithampur unit-1 manufacturing facility has received an...
Pharmaceutical major, Lupin Ltd on 18 September announced that they have signed a non-exclusive patent licensing arrangement to bring the novel gastrointestinal medication Vonoprazan tablets...